Insights from pharmacokinetic models of host-microbiome drug metabolism
Increasing evidence suggests a role of the gut microbiota in patients’ response to medicinal drugs. In our recent study, we combined genomics of human gut commensals and gnotobiotic animal experiments to quantify microbiota and host contributions to drug metabolism. Informed by experimental data, we...
Main Authors: | Maria Zimmermann-Kogadeeva, Michael Zimmermann, Andrew L. Goodman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-05-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19490976.2019.1667724 |
Similar Items
-
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
by: Anne Smits, et al.
Published: (2020-05-01) -
Intestinal metabolism of baicalein after oral administration in mice: Pharmacokinetics and mechanisms
by: Bowei Zhang, et al.
Published: (2019-03-01) -
Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches
by: Yaru Peng, et al.
Published: (2021-01-01) -
Orally Administered Crocin Protects Against Cerebral Ischemia/Reperfusion Injury Through the Metabolic Transformation of Crocetin by Gut Microbiota
by: Yue Zhang, et al.
Published: (2019-04-01) -
A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children
by: Erik Sjögren, et al.
Published: (2021-02-01)